A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher

BACKGROUND: Studies of octreotide in hepatocellular carcinoma have yielded conflicting results. Since past studies have excluded patients with highly advanced disease and given the fact that octreotide offers several potential physiologic benefits in patients with advanced cirrhosis, such as improvi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Shah, Usman, O’Neil, Bert, Allen, Jill, Goldberg, Richard M., Bernard, Steven, Moore, Dominic, Venook, Alan P., Morse, Michael M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: International Society of Gastrointestinal Oncology 2009
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684718/
https://ncbi.nlm.nih.gov/pubmed/19461906
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg